Report overview
This report aims to provide a comprehensive presentation of the global market for Hematopoietic Stem Cells (HSCs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematopoietic Stem Cells (HSCs). This report contains market size and forecasts of Hematopoietic Stem Cells (HSCs) in global, including the following market information:
Global Hematopoietic Stem Cells (HSCs) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Hematopoietic Stem Cells (HSCs) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Leukocyte Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hematopoietic Stem Cells (HSCs) include Kite Pharma Inc., Thermo Fisher Scientific, PromoCell, CellGenix Technologie Transfer GmbH, Cesca Therapeutics Inc., R&D Systems, Genlantis, Lonza Group Ltd. and TiGenix N.V., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hematopoietic Stem Cells (HSCs) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hematopoietic Stem Cells (HSCs) Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Hematopoietic Stem Cells (HSCs) Market Segment Percentages, by Type, 2022 (%)
Leukocyte
Lymphocytes
Red Blood Cells
Platelets
Global Hematopoietic Stem Cells (HSCs) Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Hematopoietic Stem Cells (HSCs) Market Segment Percentages, by Application, 2022 (%)
Blood System Diseases
Autoimmune Diseases
Other
Global Hematopoietic Stem Cells (HSCs) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Hematopoietic Stem Cells (HSCs) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hematopoietic Stem Cells (HSCs) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hematopoietic Stem Cells (HSCs) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Kite Pharma Inc.
Thermo Fisher Scientific
PromoCell
CellGenix Technologie Transfer GmbH
Cesca Therapeutics Inc.
R&D Systems
Genlantis
Lonza Group Ltd.
TiGenix N.V.
ScienCell Research Laboratories
China Cord Blood Corporation
Vcanbio
Boyalife
Beike Biotechnology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hematopoietic Stem Cells (HSCs), market overview.
Chapter 2: Global Hematopoietic Stem Cells (HSCs) market size in revenue.
Chapter 3: Detailed analysis of Hematopoietic Stem Cells (HSCs) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hematopoietic Stem Cells (HSCs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
